Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12617000191392
Ethics application status
Approved
Date submitted
2/02/2017
Date registered
6/02/2017
Date last updated
16/10/2017
Type of registration
Prospectively registered

Titles & IDs
Public title
Does the use of muscle relaxants during anaesthesia for hip arthroscopies influence the pressure on the perineum?
Scientific title
Influence of deep muscle relaxation on the pudendal nerve by the perineal post of a traction table during hip arthroscopic surgery
Secondary ID [1] 291056 0
none
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
pressure on the pudendal nerve 301852 0
Anaesthesia for hip arthroscopic surgery 301861 0
Condition category
Condition code
Surgery 301532 301532 0 0
Other surgery
Anaesthesiology 301541 301541 0 0
Anaesthetics

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Muscle relaxation after induction of anaesthesia in patients undergoing hip arthroscopic surgery on a traction table. Relaxation will be achieved by intravenous administration of rocuronium 0.6 mg/kg (by the attending anaesthetist) approx. 5 minutes after traction has been applied to the operated leg. The pressure of the perineal post of the traction table on the patients' perineum will be measured by means of a pressure sensor mat build into the post before and 90 s after the muscle relaxant is applied. In addition, the width of the hip joint will be measured via xray before and after paralysis. In case the width of the hip joint increases after paralysis, the traction on the patient's leg will be decreased until the width of the joint is as before paralysis. At this stage, another pressure measurement at the pudendal nerve will be performed.
Intervention code [1] 297045 0
Treatment: Drugs
Comparator / control treatment
no control group; patients act as own control (before and after administration of the muscle relaxant)
Control group
Uncontrolled

Outcomes
Primary outcome [1] 300936 0
Pressures on the participants' perineum by the perineal post of a traction table by means of a pressure sensor mat built into the perineal post of the traction table.
Timepoint [1] 300936 0
intra-operatively; directly before and 90 seconds after intravenous administration of rocuronium 0.6 mg/kg, as well as after reducing traction on the leg (in order to reduce hip joint width to pre-paralysis status).
Primary outcome [2] 303673 0
Width of the hip joint before and after neuromuscular paralysis in patients undergoing hip arthroscopic surgery on a traction table. The width of the joibt is measured via xrays taken during and after the traction.
Timepoint [2] 303673 0
Before and after paralysis at the begining of surgery.
Secondary outcome [1] 331243 0
none
Timepoint [1] 331243 0
none

Eligibility
Key inclusion criteria
40 patients (male and female), ASA 1-2, aged 18-60 years scheduled for elective hip arthroscopic surgery deemed appropriate (by attending anaesthetist) under relaxant general anaesthesia with propofol/opioid.
Minimum age
18 Years
Maximum age
60 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
allergy to rocuronium or sugammadex, neuromuscular disorder, severe peripheral neuropathy or anatomy excluding neuromuscular monitoring at the ulnar nerve, neuraxial anaesthesia or a femoral/sciatic nerve block prior to observation interval, age < 18 > 60 years, incapacity to consent.

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
none
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
n/a
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Phase 4
Type of endpoint/s
Efficacy
Statistical methods / analysis
All data will be checked for normal distribution (Komogorov-Smirnov Test) and will be displayed as either mean (SD) or median (percentiles). Data comparing numerical values (i.e. pre- and post- paralysis pressures) will be compared using either students t-test or a non-parametric alternative, as appropriate. Relationships between categorical parameters may be explored using the chi-square or Fishers exact tests.

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
3/04/2017
Actual
1/05/2017
Date of last participant enrolment
Anticipated
29/12/2017
Actual
Date of last data collection
Anticipated
29/12/2017
Actual
Sample size
Target
40
Accrual to date
20
Final
Recruitment in Australia
Recruitment state(s)
WA
Recruitment hospital [1] 7423 0
Joondalup Health Campus - Joondalup
Recruitment hospital [2] 7424 0
Glengarry Private Hospital - Duncraig
Recruitment postcode(s) [1] 15228 0
6027 - Joondalup
Recruitment postcode(s) [2] 15229 0
6023 - Duncraig

Funding & Sponsors
Funding source category [1] 295496 0
Hospital
Name [1] 295496 0
Royal Perth Hospital
Country [1] 295496 0
Australia
Primary sponsor type
Individual
Name
Prof. Thomas Ledowski
Address
Royal Perth Hospital
Medical REsearch Foundation
Level 2 RPH MRF Building
Rear 50 Murray Street
Perth WA 6000
Country
Australia
Secondary sponsor category [1] 294315 0
None
Name [1] 294315 0
Address [1] 294315 0
Country [1] 294315 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 296826 0
Ethics Committee of the Joondalup Health Campus
Ethics committee address [1] 296826 0
Ethics committee country [1] 296826 0
Australia
Date submitted for ethics approval [1] 296826 0
01/09/2016
Approval date [1] 296826 0
27/10/2016
Ethics approval number [1] 296826 0
1628

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 72142 0
Prof Thomas Ledowski
Address 72142 0
Royal Perth Hospital
Medical Research Foundation
Level 2 RPH MRF Building
Rear 50 Murray Street
Perth WA 6000
Country 72142 0
Australia
Phone 72142 0
+61892240210
Fax 72142 0
Email 72142 0
[email protected]
Contact person for public queries
Name 72143 0
Thomas Ledowski
Address 72143 0
Royal Perth Hospital
Medical Research Foundation
Level 2 RPH MRF Building
Rear 50 Murray Street
Perth WA 6000
Country 72143 0
Australia
Phone 72143 0
+61892240210
Fax 72143 0
Email 72143 0
[email protected]
Contact person for scientific queries
Name 72144 0
Thomas Ledowski
Address 72144 0
Royal Perth Hospital
Medical Research Foundation
Level 2 RPH MRF Building
Rear 50 Murray Street
Perth WA 6000
Country 72144 0
Australia
Phone 72144 0
+61892240210
Fax 72144 0
Email 72144 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbaseDeep neuromuscular paralysis during hip arthroscopic surgery: Influence on perineal tissue pressures and hip joint width.2020https://dx.doi.org/10.1093/jhps/hnaa049
N.B. These documents automatically identified may not have been verified by the study sponsor.